Bernardo Rodrigues

Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis

A. Bobrowska, J. Sermon, M. Sebastian, 2022, Targeted Oncology.

An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

J. Wolf, Jedelyn Cabrieto, Nicole Erdmann, 2023, Advances in Therapy.